This call is currently open for submissions. Applications can be submitted at any time and will be reviewed on a quarterly basis. Deadlines to submit an application for review are March 31, June 30, September 30 and December 31 annually. Applicants will be notified with the results of the application review prior to the next submission deadline.
To apply, please visit our How to Apply page for details and instructions.
Grant Opportunity
The Brain Health Medicines Scholar Award provides funding and drug development support to researchers whose work aims to treat, prevent or cure Alzheimer's disease and related dementias. The award includes:
- One-year grant
- $100,000 with appropriate justification
- Potential to renew for a second year based on milestones achieved
- Dedicated Project Manager for the duration of the award
- Drug development, commercial strategy and business development support from Harrington's Therapeutics Development Center experts
- Opportunity to quality for up to $400,000 in additional funding and drug development support
Join our emailing list to become a part of our community and receive periodic communications about grant funding opportunities, as well as news and updates.
Eligibility Criteria
- MD or PhD (or equivalent)
- Faculty position at an accredited academic medical center, university or research institution in the US, Canada, or UK, and conduct the majority of their research at that institution
- A project must have a single Principal Investigator (PI) who will be named the Scholar and who is responsible for project oversight and financial management. The PI may engage collaborators, core labs or commercial CROs to execute any portion of the project.
- Past recipients of Harrington awards may submit new and distinct proposals, but may not seek additional support for previously funded projects.
Discoveries Sought
The Brain Health Medicine Scholars selection committee seeks:
- Discoveries demonstrating rigorous science, creativity, innovation, and potential for clinical impact
- Any therapeutic modality
- Novel, validated targets
HOW TO APPLY APPLY NOW
